inflammatory diseases

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

AbbVie hands back phase 1 duties for inflammation drug to Ose

The Big Pharma now wants the French biotech to keep an eye on the asset for a while longer.
James Waldron Dec 8, 2025 5:39am
Lung

GSK pens $750M deal for COPD-focused oligonucleotide in phase 1

Oct 28, 2025 6:45am
An artists concept of T cells attacking a cancer cell The T cells are in red while the cancer is light blue The cells are

Nobel winner turns rogue T cells into their own treatment

Oct 23, 2025 10:35am
two gold elevators opening

British biotech elevates with $70M and midstage arthritis asset

Oct 21, 2025 7:01pm
Nobel Prize medal with background of 100 bills

How Nobel-winning cells could become a 'universal drug'

Oct 21, 2025 2:00pm
Hiking gear with a forest in the background

Expedition resupplies for ph. 2 COPD voyage with $165M series A

Oct 9, 2025 9:50am